SBIR Phase II: An adjuvant-based antimicrobial coating (COVID-19)

该奖项的全部或部分资金来自《2021年美国救援计划法案》(公法117-2)。这一小企业创新研究(SBIR)第二阶段项目的更广泛影响是推进一项能够提供对病毒、细菌和真菌的残留抗菌活性的技术。新冠肺炎疫情加剧了人们对各种微生物以及当前消毒产品局限性的担忧。拟议的项目推进了喷雾技术的转化，该技术在干燥后会留下一层薄的透明薄膜，粘在表面和氯气上，从而使表面能够被消毒长达一个月。该膜实质上延长了氯基消毒剂的使用寿命。拟议的项目将继续开发一种新型的抗菌涂层，该涂层已被证明对病毒、细菌和真菌有效。该项目将优化薄膜的产品配方和具有可重复使用的残留卫生性能的补充解决方案。该项目将进一步推进制造规模，以确保产品的大量具有成本效益的生产能力并进行现场试验。该奖项反映了NSF的法定使命，并通过使用基金会的智力优势和更广泛的影响审查标准进行评估，被认为值得支持。

This award is funded in whole or in part under the American Rescue Plan Act of 2021 (Public Law 117-2). The broader impact of this Small Business Innovation Research (SBIR) Phase II project is to advance a technology that can provide residual antimicrobial activity against viruses, bacteria, and fungi. The COVID-19 pandemic has heightened concerns about microorganisms of all kinds and the limitations of current disinfecting products. The proposed project advances translation of a spray-on technology that, when dried, leaves a thin transparent film sticking both to the surface and to chlorine, thus enabling the surface to be disinfected for up to a month. The film essentially extends the useful life of chlorine-based disinfectants. The proposed project will continue development of a novel antimicrobial coating that has proven efficacy against viruses, bacteria, and fungi. This project will optimize the product formulation for the film and a complementary solution with reproducible residual sanitation performance. The project will further advance the manufacturing scale-up to ensure large volume cost-effective production capabilities for the product and conduct field trials.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.